Ignite Creation Date:
2024-05-06 @ 11:14 AM
Last Modification Date:
2024-10-26 @ 12:42 PM
Study NCT ID:
NCT03469557
Status:
COMPLETED
Last Update Posted:
2020-09-30
First Post:
2018-02-08
Brief Title:
BGB A317 in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable Locally Advanced or Metastatic Esophageal Gastric or Gastroesophageal Junction Carcinoma
Sponsor:
BeiGene
Organization:
BeiGene
Organization Data
Organization:
BeiGene
Class:
INDUSTRY
Study ID:
BGB-A317-205
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
BeiGene
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None